United States· US:0642-0093_303eca3e-0bc8-1bf8-e063-6294a90a82d8
Vitafol
A medicinal product containing doconexent; niacinamide; .alpha.-tocopherol acetate, dl-; cholecalciferol; beta carotene; ascorbic acid; thiamine mononitrate; riboflavin; pyridoxine hydrochloride; cyanocobalamin; iron; zinc oxide; cupric oxide; potassium iodide; magnesium oxide; folic acid; levomefolate calcium, registered in United States by Exeltis USA, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DOCONEXENT; NIACINAMIDE; .ALPHA.-TOCOPHEROL ACETATE, DL-; CHOLECALCIFEROL; BETA CAROTENE; ASCORBIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; IRON; ZINC OXIDE; CUPRIC OXIDE; POTASSIUM IODIDE; MAGNESIUM OXIDE; FOLIC ACID; LEVOMEFOLATE CALCIUM
- Manufacturer
- Exeltis USA, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1106420093031 BLISTER PACK in 1 BOX (0642-0093-03) / 4 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- ndc1106420093305 BLISTER PACK in 1 BOX (0642-0093-30) / 6 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- ndc110642-0093-03
- ndc110642-0093-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d871899d-353b-4b3e-9f1f-8896151baf14 GET /v1/drugs/d871899d-353b-4b3e-9f1f-8896151baf14?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200; 15; 9; 25; 330; 30; 1.6; 1.8; 2.5; 12; 29; 25; 2; 150; 20; 680; 1020",
"substance": "DOCONEXENT; NIACINAMIDE; .ALPHA.-TOCOPHEROL ACETATE, DL-; CHOLECALCIFEROL; BETA CAROTENE; ASCORBIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; IRON; ZINC OXIDE; CUPRIC OXIDE; POTASSIUM IODIDE; MAGNESIUM OXIDE; FOLIC ACID; LEVOMEFOLATE CALCIUM",
"productndc": "0642-0093",
"dosage_form": "CAPSULE, LIQUID FILLED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about doconexent; niacinamide; .alpha.-tocopherol acetate, dl-; cholecalciferol; beta carotene; ascorbic acid; thiamine mononitrate; riboflavin; pyridoxine hydrochloride; cyanocobalamin; iron; zinc oxide; cupric oxide; potassium iodide; magnesium oxide; folic acid; levomefolate calcium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.